The stimulants revisited. (Q34005063)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

The stimulants revisited (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Wilens TE

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Spencer TJ

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

Child and Adolescent Psychiatric Clinics of North America

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

573-603, viii

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

The normalizing effects of methylphenidate on the classroom behavior of ADDH children

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Clinical effects of methylphenidate and thioridazine in intellectually subaverage children.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A review of stimulant drug research with hyperactive children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

The Effects of Methylphenidate on the Interactions of Preschool ADHD Children with Their Mothers

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Hyperactive girls and boys: stimulant drug effects on mother-child interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

The Effects of Methylphenidate on the Mother-Child Interactions of Hyperactive Children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Childhood chemotherapy and later drug abuse and growth curve: a follow-up study of 30 adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

The naturalistic course of pharmacologic treatment of children with maniclike symptoms: a systematic chart review.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Sustained release methylphenidate: pharmacokinetic studies in ADDH males

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

CASE STUDY Methylphenidate Treatment of Hyperactive Autistic Children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Methylphenidate-induced delusional disorder in a child with attention deficit disorder with hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A controlled trial of methylphenidate in black adolescents. Attentional, behavioral, and physiological effects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Pemoline pharmacokinetics and long term therapy in children with attention deficit disorder and hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: II. Information processing.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A developmental dose-response analysis of the effects of methylphenidate on the peer interactions of attention deficit disordered boys.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Response to methylphenidate in children with ADHD and comorbid anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. American Academy of Child and Adolescent Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Using psychostimulants to treat behavioral disorders of children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Response of children with ADHD to methylphenidate: interaction with internalizing symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Stimulant drug treatment of hyperactivity: biochemical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Effects of Stimulant Drugs on Academic Performance in Hyperactive and Learning Disabled Children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Methylphenidate in aggressive-hyperactive boys: I. Effects on peer aggression in public school settings

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Replacement medication for cocaine dependence: methylphenidate.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A controlled trial of stimulant medication in children with the fragile X syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Adverse side effects of methylphenidate among mentally retarded children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Prediction of response to methylphenidate among children with ADHD and mental retardation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Anger control in response to verbal provocation: effects of stimulant medication for boys with ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Enantioselective aspects of the disposition of dl-threo-methylphenidate after the administration of a sustained-release formulation to children with attention deficit-hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Psychostimulant rebound in attention deficit disordered boys

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Effects of methylphenidate on adolescents with a childhood history of attention deficit disorder: I. Clinical findings

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Effects of methylphenidate dosage in hyperactive reading-disabled children: I. Behavior and cognitive performance effects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Use of stimulants in the medically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Methylphenidate effects on symptoms of attention deficit disorder in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

The absorption of sustained-release methylphenidate formulations compared to an immediate-release formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Tricyclic antidepressants in the treatment of children with attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Dextroamphetamine: Cognitive and Behavioral Effects in Normal Prepubertal Boys

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Hyperactivity and methylphenidate: rate-dependent effects on attention

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Attention deficit disorder with hyperactivity and methylphenidate: the effects of dose and mastery level on children's learning performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Attention deficit disorder and methylphenidate: a multilevel analysis of dose-response effects on children's impulsivity across settings

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Depression of Growth in Hyperactive Children on Stimulant Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Oral pemoline kinetics in hyperactive children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Growth of Hyperactive Children Treated With Methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Childhood hyperactivity and psychostimulants: a review of extended treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Hyperactivity in preschoolers and the effect of methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Comorbidity between ADDH and learning disability: a review and report in a clinically referred sample

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Methylphenidate in 6-hydroxydopamine-treated developing rat pups. Effects on activity and maze performance

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Pemoline-associated hepatic failure: a critical analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Does methylphenidate constrict cognitive functioning?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

More Frequent Diagnosis of Attention Deficit–Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Differential Effects of Methylphenidate on Working Memory in ADHD Children with and without Comorbid Anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Effects of methylphenidate in adolescents with attention deficit disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

The Personality Inventory for Children and response to methylphenidate: preliminary evidence for predictive utility.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Methylphenidate and haloperidol in children. Effects on attention, memory, and activity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Attention deficit hyperactivity disorder in adolescent mania

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Social judgment processes in hyperactive boys: effects of methylphenidate and comparisons with normal peers

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Mania-Like Symptoms Suggestive of Childhood-Onset Bipolar Disorder in Clinically Referred Children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Effects of age and Ritalin dosage on the mother-child interactions of hyperactive children.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

Natural social behaviors in hyperactive children: dose effects of methylphenidate

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930108-1

7 January 2021

10.1016/S1056-4993(18)30108-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10944658%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference